Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Doorn, H.C. van

Refine Results

Resource Type

Availability

Creation Date

Show more

Author

Show more

Language

Search results

  • RSS Feed
(21 - 36 of 36)

Pages

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing
DECISION MAKING FOR RISK-REDUCING SURGERY IN BRCA1/2 MUTATION CARRIERS IN THE PROSPECTIVE MULTICENTRE TUBA STUDY
Raman spectroscopy for cancer detection and cancer surgery guidance: translation to the clinics
A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?
Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible
Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I
A PILOT-STUDY OF A SEXUAL REHABILITATION PROGRAMME FOR GYNECOLOGICAL CANCER PATIENTS AFTER PELVIC RADIATION THERAPY
SENTINEL NODES AND VULVAR CANCER: LONG-TERM FOLLOW-UP OF THE GRONINGEN INTERNATIONAL STUDY ON SENTINEL NODES IN VULVAR CANCER (GROINSS-V-I)
FEASIBILITY OF REPEAT SENTINEL LYMPH NODE (SLN) PROCEDURE IN PATIENTS WITH RECURRENT VULVAR SQUAMOUS CELL CARCINOMA
Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction
Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Pages